Fertility Epigenetic Benchmarking Market, By Product Type (Instruments & Equipment, Assay Kits & Reagents, Testing & Analytical Services, Bioinformatics Software & Platforms and Others), By Technology, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Market Research Image
Report ID ANV6318
Published Date November 2026
Pages 303
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

Fertility Epigenetic Benchmarking market size was valued at US$ 660.8 Million in 2025, expanding at a CAGR of 19.8% from 2026 to 2033.

Fertility epigenetic benchmarking involves analysing the chemical changes to the DNA within an individual, primarily through DNA methylation, and comparing these to benchmark patterns. These marks do not alter the DNA itself; it demonstrates gene expression and has been influenced by factors such as age, lifestyle and environment. The labs use the marks to be able to tell how old the ovaries are and how likely the sperm are going to perform, and also to be able to compare the patient to specific fertility benchmarks. It gives extra information for both the couple and the clinician to aid them in making proper decisions regarding their treatment route. The early results from the test show that women who conceive successfully through IVF usually have lower epigenetic age compared to other women, but the current methods can only be used as complementary to other tests.

Fertility Epigenetic Benchmarking Market- Market Dynamics

Rising Demand For Personalised Fertility Assessment To Boost Market Demand

The rising demand for personalised fertility assessment is driving the Fertility Epigenetic Benchmarking Market. As there is a constantly increasing demand for assessing the factors that affect reproduction, embryo development and fertility outcomes through personalised methods through the use of epigenetics. In June 2026, according to the Human Fertilisation and Embryology Authority (Gov) report \"Fertility Treatment: Trends and Figures\", 53,000 patients had undergone IVF treatment, which is compared to 19,000, marking a nearly threefold increase.

Moreover, the average age of patients that were starting IVF treatment was 34.8 years old, whereas the average age of single patients undergoing such a procedure was 35.4 years old. In addition, 48% of all IVF procedures were conducted using frozen embryos, which indicates that the number of procedures of this kind has been growing and different kinds of fertility treatment procedures have been being used. Finally, egg-freezing patients have increased from about 700 to 5,580, reflecting changing fertility preservation preferences and the need for more personalised fertility assessment. These trends highlight the growing importance of personalised fertility assessment and epigenetic insights in improving reproductive health and treatment outcomes.

Fertility Epigenetic Benchmarking Market- Segmentation Analysis:

The Global Fertility Epigenetic Benchmarking market is segmented on the basis of Product Type, Technology, Application, End User, and Region.

From a technology perspective, DNA methylation analysis plays a prominent role in the market because of its wide usage in the field of epigenetics studies, fertility testing, and biological age identification. DNA methylation analysis is commonly used in epigenetic clocks, sperm analysis, and fertility reference panels and hence becomes an essential technology in laboratories and fertility clinics. In January 2026, Inherent Biosciences published a multicenter peer-reviewed research study that demonstrated the clinical value of their SpermQT™ epigenetic sperm quality test. The test measures the production, maturity, and embryo development of sperm based on the DNA methylation analysis. The study was carried out on 537 couples at 10 fertility clinics. This study demonstrates how epigenetics can help personalize fertility decisions.

Fertility Epigenetic Benchmarking Market- Geographical Insights

The Fertility Epigenetic Benchmarking market is well established in North America because of several reasons, including the existence of many fertility clinics, as well as high levels of funding from the governments for research in this field. In March 2026, according to the American Society for Reproductive Medicine (Org) in its report \"For the First Time, More Than 100,000 Babies Born Through IVF in the U.S. in a Single Year\", 364 fertility clinics have reported their results to the Society for Assisted Reproductive Technology (SART). The number of IVF treatment cycles was 449,772, and there were 97,549 successful treatments, which resulted in 100,158 babies born in the United States through IVF across the United States. This continues to drive North American growth by increasing demand for advanced fertility assessment and epigenetic testing solutions.

India Fertility Epigenetic Benchmarking market - Country Insights

India is expected to contribute to the growth of the Fertility Epigenetic Benchmarking market due to rising infertility cases, high reproductive health awareness and robust healthcare infrastructure. For instance, in June 2025, according to the Indian Journal of Community Health Org, in its research article “Women’s Reproductive Health in India: Connecting Government Policies and Programmes with NFHS-5 Data\", the rate of adoption of family planning went up from 53.5% to 66.7%.

 This can also be seen in the increase in modern family planning adoption from 47.8% to 56.4% during the same time period, with a reduction in the unmet need for family planning from 12.9% to 9.4%. Institutional deliveries also went up from 78.9% to 88.6%, which reflects the increasing awareness regarding reproductive and maternal health and family planning practices in India. These improvements are expected to support demand for fertility assessment and epigenetic benchmarking solutions across India\'s reproductive healthcare sector.

Fertility Epigenetic Benchmarking Market- Competitive Landscape:

The Fertility Epigenetic Benchmarking market is a young and fragmented market, which consists of specialised epigenetics diagnostics companies, genomics technology vendors and laboratory services. The key players in the market are Illumina, TruDiagnostic, Inherent Biosciences (Path Fertility), Genomic Prediction and Diagenode (Hologic), which offer methylation arrays, clinical testing, laboratory services and fertility testing products. Such trends have been driven by the companies offering a high level of clinical evidence, high accuracy, ease of sampling, and clinic collaboration. In October 2026, Path Fertility released new data at ASRM 2026 for their sperm epigenetic test predicting IUI success in different clinic and physician samples. This is an indication of increasing demand for clinical evidence. This market is set to continue to innovate with more validation studies being carried out.

Recent Developments:

  • In March 2026, Illumina introduced the Infinium Bovine Methylation Array, designed by RUMIGEN, a dedicated methylation array for cattle. It provides coverage of around 42,000 CpG sites associated with traits such as fertility, age and metabolic stress.

 SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Inherent Biosciences, Inc.
  • Illumina, Inc.
  • Hologic, Inc.
  • Agilent Technologies, Inc.
  • Oxford Nanopore Technologies plc
  • Zymo Research Corporation
  • EpigenTek Group Inc.
  • EpiCypher, Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Element Biosciences, Inc.
  • Revvity, Inc.
  • Abcam plc
  • Eurofins Scientific SE
  • Igenomix
  • Juno Genetics
  • Natera, Inc.
  • Fulgent Genetics, Inc.
  • Labcorp
  • Quest Diagnostics Incorporated
  • Sapyen
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Instruments & Equipment
  • Assay Kits & Reagents
  • Testing & Analytical Services
  • Bioinformatics Software & Platforms
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • RNA Sequencing
  • DNA Methylation
  • Histone Modification
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Predictive Diagnostics and Prognostics
  • Assisted Reproductive Technology (ART)
  • Male Infertility
  • Female Infertility
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Contract Research Organizations (CROs)
  • Pharmaceutical and Biotechnology Companies
  • Fertility Clinics and Hospitals
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

TABLE OF CONTENT
1. Fertility Epigenetic Benchmarking Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Fertility Epigenetic Benchmarking Key Market Trends
3.1. Fertility Epigenetic Benchmarking Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Fertility Epigenetic Benchmarking Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Fertility Epigenetic Benchmarking Market Opportunities
3.4. Fertility Epigenetic Benchmarking Market Future Trends
4. Fertility Epigenetic Benchmarking Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Fertility Epigenetic Benchmarking Market : Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Fertility Epigenetic Benchmarking Market Landscape
6.1. Fertility Epigenetic Benchmarking Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Fertility Epigenetic Benchmarking Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
7.1.2. Instruments & Equipment
7.1.3. Assay Kits & Reagents
7.1.4. Testing & Analytical Services
7.1.5. Bioinformatics Software & Platforms
7.1.6. Others
8. Fertility Epigenetic Benchmarking Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. RNA Sequencing
8.1.3. DNA Methylation
8.1.4. Histone Modification
8.1.5. Others
9. Fertility Epigenetic Benchmarking Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Predictive Diagnostics and Prognostics
9.1.3. Assisted Reproductive Technology (ART)
9.1.4. Male Infertility
9.1.5. Female Infertility
9.1.6. Others
10. Fertility Epigenetic Benchmarking Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Contract Research Organizations (CROs)
10.1.3. Pharmaceutical and Biotechnology Companies
10.1.4. Fertility Clinics and Hospitals
10.1.5. Academic and Research Institutes
10.1.6. Diagnostic Laboratories
10.1.7. Others
11. Fertility Epigenetic Benchmarking Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Fertility Epigenetic Benchmarking Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Fertility Epigenetic Benchmarking Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Denmark Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Fertility Epigenetic Benchmarking Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Fertility Epigenetic Benchmarking Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Fertility Epigenetic Benchmarking Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Fertility Epigenetic Benchmarking Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Inherent Biosciences, Inc.
12.2.2. Illumina, Inc.
12.2.3. Hologic, Inc.
12.2.4. Agilent Technologies, Inc.
12.2.5. Oxford Nanopore Technologies plc
12.2.6. Zymo Research Corporation
12.2.7. EpigenTek Group Inc.
12.2.8. EpiCypher, Inc.
12.2.9. Merck KGaA
12.2.10. Thermo Fisher Scientific Inc.
12.2.11. Element Biosciences, Inc.
12.2.12. Revvity, Inc.
12.2.13. Abcam plc
12.2.14. Eurofins Scientific SE
12.2.15. Igenomix
12.2.16. Juno Genetics
12.2.17. Natera, Inc.
12.2.18. Fulgent Genetics, Inc.
12.2.19. Labcorp
12.2.20. Quest Diagnostics Incorporated
12.2.21. Sapyen
12.2.22. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Inherent Biosciences, Inc.
  • Illumina, Inc.
  • Hologic, Inc.
  • Agilent Technologies, Inc.
  • Oxford Nanopore Technologies plc
  • Zymo Research Corporation
  • EpigenTek Group Inc.
  • EpiCypher, Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Element Biosciences, Inc.
  • Revvity, Inc.
  • Abcam plc
  • Eurofins Scientific SE
  • Igenomix
  • Juno Genetics
  • Natera, Inc.
  • Fulgent Genetics, Inc.
  • Labcorp
  • Quest Diagnostics Incorporated
  • Sapyen
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Instruments & Equipment
  • Assay Kits & Reagents
  • Testing & Analytical Services
  • Bioinformatics Software & Platforms
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • RNA Sequencing
  • DNA Methylation
  • Histone Modification
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Predictive Diagnostics and Prognostics
  • Assisted Reproductive Technology (ART)
  • Male Infertility
  • Female Infertility
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Contract Research Organizations (CROs)
  • Pharmaceutical and Biotechnology Companies
  • Fertility Clinics and Hospitals
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others

GLOBAL FERTILITY EPIGENETIC BENCHMARKING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA
Choose License Type

assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved